Target
Transient receptor potential cation channel subfamily A member 1
Ligand
BDBM481809
Substrate
n/a
Meas. Tech.
FLIPR Assay
IC50
168±n/a nM
Citation
 Chen, HShore, DVillemure, EVolgraf, MHu, BLu, ACridland, AWard, SBeaumier, FDery, MLarouche-Gauthier, R Oxadiazolones as transient receptor potential channel inhibitors US Patent  US10913742 Publication Date 2/9/2021 
Target
Name:
Transient receptor potential cation channel subfamily A member 1
Synonyms:
ANKTM1 | Ankyrin-like with transmembrane domains protein 1 | TRPA1 | TRPA1_HUMAN | Transformation-sensitive protein p120 | Transient receptor potential cation channel subfamily A member 1 (TRPA1)
Type:
Protein
Mol. Mass.:
127514.20
Organism:
Homo sapiens (Human)
Description:
O75762
Residue:
1119
Sequence:
MKRSLRKMWRPGEKKEPQGVVYEDVPDDTEDFKESLKVVFEGSAYGLQNFNKQKKLKRCDDMDTFFLHYAAAEGQIELMEKITRDSSLEVLHEMDDYGNTPLHCAVEKNQIESVKFLLSRGANPNLRNFNMMAPLHIAVQGMNNEVMKVLLEHRTIDVNLEGENGNTAVIIACTTNNSEALQILLKKGAKPCKSNKWGCFPIHQAAFSGSKECMEIILRFGEEHGYSRQLHINFMNNGKATPLHLAVQNGDLEMIKMCLDNGAQIDPVEKGRCTAIHFAATQGATEIVKLMISSYSGSVDIVNTTDGCHETMLHRASLFDHHELADYLISVGADINKIDSEGRSPLILATASASWNIVNLLLSKGAQVDIKDNFGRNFLHLTVQQPYGLKNLRPEFMQMQQIKELVMDEDNDGCTPLHYACRQGGPGSVNNLLGFNVSIHSKSKDKKSPLHFAASYGRINTCQRLLQDISDTRLLNEGDLHGMTPLHLAAKNGHDKVVQLLLKKGALFLSDHNGWTALHHASMGGYTQTMKVILDTNLKCTDRLDEDGNTALHFAAREGHAKAVALLLSHNADIVLNKQQASFLHLALHNKRKEVVLTIIRSKRWDECLKIFSHNSPGNKCPITEMIEYLPECMKVLLDFCMLHSTEDKSCRDYYIEYNFKYLQCPLEFTKKTPTQDVIYEPLTALNAMVQNNRIELLNHPVCKEYLLMKWLAYGFRAHMMNLGSYCLGLIPMTILVVNIKPGMAFNSTGIINETSDHSEILDTTNSYLIKTCMILVFLSSIFGYCKEAGQIFQQKRNYFMDISNVLEWIIYTTGIIFVLPLFVEIPAHLQWQCGAIAVYFYWMNFLLYLQRFENCGIFIVMLEVILKTLLRSTVVFIFLLLAFGLSFYILLNLQDPFSSPLLSIIQTFSMMLGDINYRESFLEPYLRNELAHPVLSFAQLVSFTIFVPIVLMNLLIGLAVGDIAEVQKHASLKRIAMQVELHTSLEKKLPLWFLRKVDQKSTIVYPNKPRSGGMLFHIFCFLFCTGEIRQEIPNADKSLEMEILKQKYRLKDLTFLLEKQHELIKLIIQKMEIISETEDDDSHCSFQDRFKKEQMEQRNSRWNTVLRAVKAKTHHLEP
  
Inhibitor
Name:
BDBM481809
Synonyms:
5-[(7-methyl-6-oxo-purin-1- yl)methyl]-3-(3- phenylcyclobutyl)-1,3,4- oxadiazol-2-one | US10913742, Example 51
Type:
Small organic molecule
Emp. Form.:
C19H18N6O3
Mol. Mass.:
378.3846
SMILES:
Cn1cnc2ncn(Cc3nn([C@H]4C[C@@H](C4)c4ccccc4)c(=O)o3)c(=O)c12 |r,wU:14.16,wD:12.11,(-8.78,-2.41,;-8.3,-.95,;-9.2,.3,;-8.3,1.54,;-6.83,1.07,;-5.5,1.84,;-4.17,1.07,;-4.17,-.47,;-2.83,-1.24,;-1.5,-.47,;-.09,-1.1,;.94,.04,;2.47,-.12,;3.4,-1.34,;4.63,-.41,;3.7,.81,;6.15,-.62,;6.74,-2.05,;8.26,-2.25,;9.2,-1.04,;8.62,.39,;7.1,.6,;.17,1.38,;.79,2.78,;-1.34,1.06,;-5.5,-1.24,;-5.5,-2.78,;-6.83,-.47,)|
Structure:
Search PDB for entries with ligand similarity: